Citadel Advisors’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-27,950
Closed -$17K 8525
2016
Q3
$17K Buy
27,950
+4,917
+21% +$3.33K ﹤0.01% 7101
2016
Q2
$16K Buy
+23,033
New +$16.3K ﹤0.01% 6682

Other funds holding MATN